Sponsored by:

Nuclear Medicine: Page 247

FDG-PET/CT shows promise in post-transplant lymphoproliferative disease
By Wayne Forrest
Wednesday, December 1 | 10:50 a.m.-11:00 a.m. | SSK13-03 | Room S505ABResearchers from the University of Nebraska Medical Center in Omaha plan to present study results at RSNA 2010 on the usefulness of FDG-PET in the early diagnosis, follow-up, and management of post-transplant lymphoproliferative disease.
November 15, 2010
PET/CT tops CT alone for head and neck squamous cell carcinoma
By Wayne Forrest
Tuesday, November 30 | 10:30 a.m.-10:40 a.m. | SSG12-01 | Room S505ABPET/CT is superior to high-resolution CT alone, particularly regarding sensitivity, in cases of head and neck squamous cell carcinoma, according to a study by researchers from Mount Sinai School of Medicine in New York City.
November 15, 2010
PEM shows potential for breast cancer surgical planning
By Kate Madden Yee
Monday, November 29 | 11:40 a.m.-11:50 a.m. | VM21-15 | Arie Crown TheaterIn this scientific session, Johns Hopkins researchers will present study results suggesting that positron emission mammography (PEM) is a helpful tool for breast cancer surgical planning in early-stage breast cancer.
November 15, 2010
How well can FDG-PET scans detect colorectal adenomas?
By Wayne Forrest
Monday, November 29 | 10:40 a.m.-10:50 a.m. | SSC13-02 | Room S505ABAlthough FDG-PET scans are sensitive in detecting malignancy and can detect colorectal polyps, Canadian researchers have found that the modality may not be foolproof in detecting lesions less than 10 mm in size.
November 15, 2010
BSGI improves breast cancer detection -- but biopsies may still be needed
By Kate Madden Yee
Monday, November 29 | 9:05 a.m.-9:15 a.m. | VM21-04 | Arie Crown TheaterBreast-specific gamma imaging (BSGI) improves the detection of breast cancer, but the modality doesn't do away with the need for biopsy when indicated by mammography or ultrasound, according to researchers from Weinstein Imaging Associates in Pittsburgh.
November 15, 2010
MBI increases breast cancer detection in dense tissue
By Kate Madden Yee
Monday, November 29 | 8:55 a.m.-9:05 a.m. | VM21-03 | Arie Crown TheaterIn this paper presentation, researchers from the Mayo Clinic in Rochester, MN, will discuss how adding molecular breast imaging (MBI) to regular screening mammography for women with dense breasts increases cancer detection.
November 15, 2010
F-18 choline PET/CT outpaces whole-body MRI in recurrent prostate cancer
By Wayne Forrest
Sunday, November 28 | 12:05 p.m.-12:15 p.m. | SSA18-09 | Room S505ABPreliminary results of an Italian study show that while whole-body MRI did not match accuracy levels of F-18 choline PET/CT in detecting the local recurrence of prostate cancer, whole-body MRI is still a promising tool in restaging patients with the disease.
November 15, 2010
FDG-PET bests CT, MRI in detecting vasculitis and infection
By Wayne Forrest
Sunday, November 28 | 11:45 a.m.-11:55 a.m. | SSA18-07 | Room S505ABWith the help of FDG-PET, researchers at the University of Erlangen-Nürnberg in Germany are detecting vasculitis and vascular stent graft/prosthesis infection in patients for whom other cross-sectional imaging modalities are not as effective.
November 15, 2010
How does FDG-PET compare to whole-body MRI in lymphoma disease?
By Wayne Forrest
Sunday, November 28 | 11:15 a.m.-11:25 a.m. | SSA18-04 | Room S505ABItalian researchers will answer that question at RSNA 2010 in Chicago, when they present their study results showing that whole-body MRI is fast and feasible for staging and restaging lymphoma disease; however, the modality falls short in matching the accuracy of FDG-PET/CT.
November 15, 2010
FDG-PET/CT tops diffusion-weighted MR imaging in breast cancer staging
By Wayne Forrest
Sunday, November 28 | 11:05 a.m.-11:15 a.m. | SSA18-03 | Room S505ABIn this presentation, researchers from the University of Duisburg-Essen in Germany will compare diffusion-weighted MRI with FDG-PET/CT for breast cancer staging.
November 15, 2010
MBI three times as effective as mammo in dense tissue
By Kate Madden Yee
Molecular breast imaging (MBI) finds three times as many cancers as conventional mammography in women with dense breasts, according to a new study published online in Radiology. The results are welcome news for this population, in which mammography appears to be less sensitive.
November 15, 2010
PEM less likely to prompt unnecessary biopsies
By Kate Madden Yee
Positron emission mammography (PEM) has improved specificity compared with MR imaging and is less likely to prompt unnecessary biopsies, according to a new study published online November 12 in Radiology.
November 14, 2010
Previous Page
Page 247 of 440
Next Page